Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Dolby Laboratories, Inc. Class A -1.32% Pre
Dolby Laboratories, Inc. Class A DLB | 73.28 73.28 | -1.32% 0.00% Pre |
Rosenblatt analyst Steve Frankel maintains Dolby Laboratories (NYSE:
DLB) with a Buy and maintains $98 price target.